Table 3 |
|||||
|
Patients with the CD20 expression below the cut-off value |
|||||
|
Histological type of B-cell lymphoma |
Number of patients below the cut-off value/Total number of patients |
% of patients below the cut-off value |
Number of patients below the cut-off value/Total number of patients |
% of patients below the cut-off value |
Percentual difference in the proportion of patients below the cut-off value between the two studies |
|
|
|||||
|
DLBCL |
11/64 |
17.2 |
6/42 |
14.3 |
2.9 |
|
FL |
4/56 |
7.1 |
2/30 |
6.7 |
0.4 |
|
CLL |
23/31 |
74.2 |
4/5 |
80.0 |
5.8 |
|
MCL |
6/34 |
17.6 |
3/20 |
15.0 |
2.6 |
|
MZL |
4/18 |
22.2 |
0/2 |
0 |
22.2 |
|
NOS |
5/15 |
33.3 |
5/15 |
33.3 |
0 |
|
Total |
53/218 |
24.3 |
20/114 |
17.5 |
6.8 |
|
|
|||||
|
DLBCL...diffuse large B-cell lymphoma, FL...follicular lymphoma, CLL chronic lympocytic leukemia, MCL...mantle cell lymphoma, MZL...marginal zone lymphoma, NOS...B- cell lymphoma unclassified, text in bold...the results has been published in our previous study (M. Horvat et al. [8]) |
|||||
|
Prevodnik et al. Diagnostic Pathology 2011 6:33 doi:10.1186/1746-1596-6-33 |
|||||
